MedTrace Logo

Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain

NCT02745470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-11-29

No results posted yet for this study

Summary

The aims this study is to explore the effect of a GLP-1 receptor agonist on the degree of brain activation and connectivity obtained by functional magnetic resonance imaging in lean and obese type 2 diabetes

Conditions

Interventions

DRUG

Lixisenatide

Colorless, transparent liquid contained in a glass prefilled syringe pen-like injection (GLP-1 receptor agonist)

OTHER

Placebo

Normal saline injection before performing fMRI

Sponsors & Collaborators

  • Seoul National University

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Young Min Cho, MD, PHD · Associate Professor Division of Endocrinology and Metabolism Department of Internal Medicine Seoul National University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745470 on ClinicalTrials.gov